FR2070104A1 - - Google Patents

Info

Publication number
FR2070104A1
FR2070104A1 FR7035490A FR7035490A FR2070104A1 FR 2070104 A1 FR2070104 A1 FR 2070104A1 FR 7035490 A FR7035490 A FR 7035490A FR 7035490 A FR7035490 A FR 7035490A FR 2070104 A1 FR2070104 A1 FR 2070104A1
Authority
FR
France
Prior art keywords
phosphonomycin
bacteria
potentiated
sept
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7035490A
Other languages
French (fr)
Other versions
FR2070104B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2070104A1 publication Critical patent/FR2070104A1/fr
Application granted granted Critical
Publication of FR2070104B1 publication Critical patent/FR2070104B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1311956 Potentiated phosphonomycins MERCK & CO Inc 28 Sept 1970 [2 Oct 1969 11 Sept 1970] 46063/70 Heading A5B The antibacterial activity of phosphonomycin antibiotics in non-human animals is potentiated by bringing bacteria into contact with an inducer selected from phosphatides, sugar phosphates and salts thereof, and polyhydric alcohols, whereby an existing phosphonomycin transport pathway in the bacteria is enhanced or a new such pathway is created, and subsequently or simultaneously bringing the bacteria into contact with a phosphonomycin antibiotic. The invention includes compositions comprising a phosphonomycin antibiotic and an inducer as indicated above.
FR707035490A 1969-10-02 1970-10-01 Expired FR2070104B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86335169A 1969-10-02 1969-10-02
US7124770A 1970-09-11 1970-09-11

Publications (2)

Publication Number Publication Date
FR2070104A1 true FR2070104A1 (en) 1971-09-10
FR2070104B1 FR2070104B1 (en) 1974-02-22

Family

ID=26752007

Family Applications (1)

Application Number Title Priority Date Filing Date
FR707035490A Expired FR2070104B1 (en) 1969-10-02 1970-10-01

Country Status (7)

Country Link
BE (1) BE756953A (en)
CA (1) CA943067A (en)
DE (1) DE2048375A1 (en)
FR (1) FR2070104B1 (en)
GB (1) GB1311956A (en)
IL (1) IL35334A (en)
NL (1) NL7014541A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660306A5 (en) * 1984-10-05 1987-04-15 Schering Spa WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS BASED ON SALTS OF (-)CIS-1,2-EPOXYPROPYLPHOSPHONIC ACID WITH AMINO ACIDS.
CH660305A5 (en) * 1984-10-05 1987-04-15 Schering Spa WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS BASED ON SALTS OF (-)CIS-1,2-EPOXYPROPYLPHOSPHONIC ACID WITH AMINO ACIDS.
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
MXPA05007485A (en) 2003-01-14 2006-01-30 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia.
AR045047A1 (en) 2003-07-11 2005-10-12 Arena Pharm Inc ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
DOP2006000010A (en) 2005-01-10 2006-07-31 Arena Pharm Inc PROCEDURE TO PREPARE AROMATIC ETERES
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP3323818A1 (en) 2010-09-22 2018-05-23 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
PL3242666T3 (en) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
BR112017027656B1 (en) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. CRYSTALLINE HABIT OF SALT-FREE PLATE OF ACID L-ARGININE (R)-2-(7-(4- CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)- 1,2,3,4-TETRA-HYDROCYCLO-PENTA[B ]INDOL-3- IL)ACETIC, PHARMACEUTICAL COMPOSITION THAT COMPRISES IT, ITS USES AND METHOD OF PREPARATION THEREOF
MX2019009841A (en) 2017-02-16 2020-01-30 Arena Pharm Inc Compounds and methods for treatment of primary biliary cholangitis.
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
IL35334A (en) 1974-01-14
NL7014541A (en) 1971-04-06
GB1311956A (en) 1973-03-28
DE2048375A1 (en) 1971-04-22
CA943067A (en) 1974-03-05
FR2070104B1 (en) 1974-02-22
BE756953A (en) 1971-04-01
IL35334A0 (en) 1971-04-28

Similar Documents

Publication Publication Date Title
FR2070104B1 (en)
CA977777A (en) Biologically active ketones
CA924973A (en) Drinking valve for poultry and livestock
GB1231943A (en)
GB1220133A (en) Improvements in or relating to refrigeration systems
GB1231942A (en)
GB1178341A (en) Phenylnaphthoic Acid Lactones as Fish-Killing Substances
CA940322A (en) Side-by-side refrigerator including low cost evaporator means
GB1124777A (en) Mechanical seal construction
GB1275708A (en) Process and compositions for combating dental calculus in animals
GR35650B (en) DETERGENT COMPOSITION.
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
GB1231944A (en)
GB1255891A (en) Cyclopentapyrimidine derivative
AU1416870A (en) Phosphorylated and phosphonylated derivatives of 2-mercapto-acetic acid n. n'-dialkylhydrazides
GB1388179A (en) Benzylpyrimidine derivatives
CA813286A (en) Nutriment compositions containing 3,6-pyridazine-diol or organotropic salts thereof
AU436586B2 (en) Bacterial culture extracts
CA822728A (en) Phosphonate stabilized nylon compositions
CA842165A (en) Ruminant nutrient compositions
AU438213B2 (en) O, o-dialkyl-2-(1,2,2-trichloroethyl)-thionothiolphosphonic acid esters and o-alkyl-s-(1,2,2-thrichloro-ethyl)-alkane-tiionothiol-phosphonic acid esters
AU432548B2 (en) Non-reversible odometer
AU421874B2 (en) Animal nutrients
CA920868A (en) Animal nutrients
CA805666A (en) 6-(3'-methyl-4'-furazanacetamido)-penicillanic acid

Legal Events

Date Code Title Description
ST Notification of lapse